I. Introduction
Non-stroidal anti-inflammatory drugs(NSAID) are commonly used drugs for years of management of pain and inflammation with good efficacy and represent most widely prescribed class of medications in the world and are used as over the counter drugs(OTC) [1] .NSAIDS inhibit cycloxyenase(COX) enzymes which catalyse the metabolism of arachidonic acid into prostaglandis.COX is available in two isoforms i.e COX-1 and COX-2 [ 2, 3] .The COX-1 enzyme is constitutive in nature involved in generating prostaglandins for physiological function like gastric protection,regulation of renal blood flow and platelet homeostasis.While COX-2 has been termed as an inducible enzymes involved in inflammation,colorectal cancer and neurodegenerative disorders [4] .A new isoform COX-3 has been recently discovered,although its role is yet not clear [5] .
Despite wide clinical use of classical NSAIDS as analgesics,anti-pyretics, and anti-inflammatory agents their gastro-intestinal toxicity(dyspepsia,peptic ulcers and gastrointestinal bleeds) is a major clinical limitation [6] .Selective COX-2 inhibitors were developed with the aim of minimizing gastrointestinal toxicity [7] .However,clinical and experimental data,as well as reviews suggest that the long term use of selective COX-2 inhibitors is associated with an increase in systolic blood pressure and cardiovascular morbidity and mortality due to myocardial infarction [8, 9] .
Acid peptic diease is very common in kashmir and use of NSAIDs acts as a predisposing factor for ulcerative disease.Nearly 10-20% of the patients who are in use of NSAIDs develop asymptomatic peptic ulceration and ulcer -related complications in 1-2% of the persons per year [10] .This warrants a cautious use of NSAIDs in high risk individuals who include the elderly,those already receiving gastro-toxic agents and those with a history of gastro-intestinal diseases [11] .So, the best alternative in such individuals would be the coadministration of NSAIDs with gastroprotective drugs.Misoprostol,an analog of prostaglandin E1,has been specifically approved for the prevention of NSAID-induced ulcers in high -risk patients [12, 13] .Proton pump inhibitors,H2 blockers have been used successfully to counter the side-effects of these anti-inflammatory drugs.
Our drug utilization was conducted to study the co-administration of non-steroidal anti-inflammatory drugs(NSAIDs) with gastroprotective drugs in postgraduate out patient unit of a university hospital.
II. Material Methods
The Study was done on 15oo patients in Skims Medical college Hospital affliated to Skims university.A written consent was taken from the patient for participation in the study.All patients using NSAIDs with or without gastroprotective agents ,between 16-70 years of age,irrespective of sex were studied.patients older than 70 years,lactating mothers,pregnant and mentally unfit were excluded .
III. Results
In a one year period from April 2014 to march 2015,a total of 1500 patients were studied.The prescriptions were assessed only once.The demographic data is depicted in , Among the 1500 prescriptions with oral NSAIDs,the number of prescriptions with gastroprotective agents were 1439(95.9%). The gastroprotective agents prescribed were proton pump inhibitors,H2 Blockers and antacids. 
IV. Discussion
One has to be guarded when prescribing analgesics to patients in Vale of Kashmir in view of the fact that acid peptic disease is very common here.The use of selective COX-2inhibitors seems to have decreased after the the cardiac adverse effects which were observed with these drugs [8, 9] .Diclofenac+ PCM+Chlorzoxazone,Aceclofenac +Thiocolchicoside,Etoricoxib,Lornoxicam,Piroxicam,PCM+Tramadol were most commonly co-prescribed NSAIDs with a gastroprotective agent-100%.Ibuprofen was the second most commonly used NSAID with a gastroprotective agent-97.92%.PPIs produce more sustained acid suppression as compared to H2 antagonists and promote ulcer healing despite continued NSAIDS Therapy [14, 15] .But in the present series H2 antagonists were the most commonly used gastroprotective agents,followed by proton pump inhibitors.This is because H2 blockers are cheap.Antacids were used least ,the reason being that these were less effective than PPIs and H2 antagonists.
Antacids are indicated only for symptomatic relief of pain and are associated with a number of drug interactions,thereby restricting their use [11] .Misoprostol,the drug indicated for the prophylaxis of high risk individuals,were not used at all.This may be because of various reasons including the higher cost,frequent side effects and the need for multiple daily dose of Misoprostol.In any case,similar or even better efficacy is obtained by proton pump inhibitors in preventing and/or treating NSAID-inuced peptic ulcers [16, 17] .Sucralfate was not used as gastroprotective drug in our series.
The drugs Paracetamol(PCM),Diclofenac,Ranitidine and Omperazole were supplied in hospital free of cost.The limitation of this study was that after initial registration there was no follow-up and no ADR reporting.The strong point was larger number of the patients,easy accessibility.
Funding: None
Conflicting Interest: None
